Daxor Corp. (DXR) Lifts Annual Dividend to 4c/Share; 0.5% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
Daxor Corporation Announces an Increased Dividend and the Appointment of Michael Feldschuh as President and Chief Executive Officer on a Temporary Basis
December 10, 2015 8:30 AM ESTNEW YORK, NY -- (Marketwired) -- 12/10/15 -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announced the payment of a dividend today along with the appointment of Michael Feldschuh, currently Executive Vice President, as President and Chief Executive Officer on a temporary basis.
The Board of Directors has unanimously approved an increase in the annual dividend payment for 2015, to $0.04 per share. This dividend will be paid on Tuesday, December 29, 2015, to Daxor shareholders of record on Tuesday, December 22nd.
Dr. Joseph Feldschuh, President and CEO... More
